The Salk Institute for Biological Studies
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$822,778,011
Investments
78%
Property, Plant, & Equipment (net)
9%
Cash & Equivalents
5%
Receivables (Non-Related)
5%
Other Assets
2%
Prepaid Expenses
<1%
Related-Party Receivables
<1%
Inventories
<1%
Liabilities in 2024 (Year End)
$173,371,281
Notes Payable / Debt (Non-Related)
53%
Payables & Accruals
27%
Deferred Revenue
14%
Other Liabilities
5%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$32,775,204
$44,354,851
+35%
Receivables (Non-Related)
$40,039,063
$42,388,745
+6%
Related-Party Receivables
$409,357
$304,304
-26%
Inventories
$23,735
$13,522
-43%
Prepaid Expenses
$1,339,293
$932,459
-30%
Investments
$641,106,221
$643,978,944
+0%
Property, Plant, & Equipment (net)
$74,740,074
$76,522,116
+2%
Other Assets
$14,822,631
$14,283,070
-4%
Total Assets
$805,255,578
$822,778,011
+2%
Liabilities
2023
2024
Change
Payables & Accruals
$41,913,073
$47,596,671
+14%
Grants Payable
$0
$0
-
Deferred Revenue
$25,958,026
$24,485,921
-6%
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$94,236,307
$92,138,737
-2%
Related-Party Payables
$0
$0
-
Other Liabilities
$10,859,097
$9,149,952
-16%
Total Liabilities
$172,966,503
$173,371,281
+0%
Net assets
2023
2024
Change
Restricted Net Assets
$519,523,356
$529,967,520
+2%
Unrestricted Net Assets
$112,765,719
$119,439,210
+6%
Net assets
2023
2024
Change
Net assets
+$632,289,075
+$649,406,730
+3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)